Nectar Lifesciences

19.88
+0.42
(2.16%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
436.40 Cr
EPS
-5.07
PE Ratio
30.47
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
56.50
52 Week Low
15.51
PB Ratio
0.46
Debt to Equity
0.65
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Nectar Lifesciences to sell its API, Formulations, and Menthol businesses to Ceph Lifesciences for ₹1,290 crore. The transaction is expected to complete by September 20, 2025, subject to approvals. Proceeds will be used for debt repayment, new investments, and shareholder rewards. Shareholder approval will be sought at an EGM on August 4, 2025.
negative
Nectar Lifesciences has reported its financial results for the fourth quarter. The company's revenue decreased to 4.29 billion rupees from 4.39 billion rupees in the same quarter last year. Additionally, Nectar Lifesciences reported a loss of 576 million rupees in Q4, compared to a profit of 105 million rupees in the corresponding period of the previous year. This represents a significant shift from profitability to loss for the company.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,672.00
#1 4,01,168.80
35.03
#1 54,729.00
12.06
#1 10,980
-18.99
47.52
6,835.00
1,81,447.80
82.80
9,360.00
0.89
2,117
23.05
58.12
1,485.00
1,19,944.60
23.31
28,409.50
7.12
5,291
30.28
45.00
3,314.20
1,12,167.60
58.54
11,539.40
11.59
1,911
10.91
53.58
2,578.30
1,06,413.90
53.56
12,207.40
19.57
1,925
-10.91
70.20
1,254.70
1,04,713.60
#1 18.86
33,741.20
12.36
5,725
21.14
39.63
979.60
98,570.70
21.11
22,573.80
13.82
3,977
-0.19
55.12
1,894.70
86,530.10
26.34
22,192.10
#1 19.94
3,024
#1 112.49
36.85
34,420.00
73,140.10
51.70
6,409.15
10.80
1,417
27.83
60.71
1,124.80
65,328.60
18.90
31,378.10
17.55
3,366
-0.50
44.29

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
8.42 %
Net Income Growth
-120.66 %
Cash Flow Change
68.12 %
ROE
-120.70 %
ROCE
202.45 %
EBITDA Margin (Avg.)
59.28 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
532
725
734
797
578
580
649
565
390
427
378
351
390
370
444
477
403
399
357
406
395
409
453
441
359
429
455
429
Expenses
471
660
667
721
513
531
592
511
373
397
345
345
350
337
396
427
361
396
343
371
359
371
410
393
320
385
410
585
EBITDA
62
66
67
76
64
49
57
54
17
31
33
6
41
33
47
50
42
3
15
35
36
38
43
49
40
44
45
-156
Operating Profit %
11 %
9 %
9 %
9 %
11 %
8 %
9 %
10 %
4 %
7 %
9 %
1 %
9 %
8 %
11 %
10 %
10 %
-2 %
0 %
4 %
9 %
7 %
9 %
11 %
11 %
10 %
10 %
-36 %
Depreciation
16
16
17
15
16
14
15
15
15
15
15
15
14
14
14
14
15
15
15
15
15
15
15
15
16
16
16
16
Interest
30
44
36
39
32
33
31
31
28
28
31
26
26
18
18
17
21
21
18
20
18
21
25
24
20
20
17
18
Profit Before Tax
15
7
14
23
16
3
10
8
-26
-11
-12
-36
1
0
15
18
6
-33
-18
2
3
2
3
11
5
9
13
-188
Tax
2
1
3
5
3
0
2
1
-9
-4
-4
5
-1
-2
6
6
2
-10
-8
-2
1
1
1
11
2
3
5
-58
Net Profit
13
6
11
18
14
3
8
7
-17
-7
-8
-41
2
2
10
12
4
-23
-9
4
2
1
2
1
3
6
8
-130
EPS in ₹
0.59
0.26
0.49
0.78
0.61
0.11
0.37
0.33
-0.75
-0.33
-0.36
-1.83
0.08
0.08
0.43
0.52
0.17
-1.00
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
2,047
Fixed Assets
934
906
881
852
825
785
772
723
662
643
690
Current Assets
1,369
1,464
1,496
1,661
1,669
1,615
1,239
1,355
1,231
1,284
1,238
Capital Work in Progress
91
99
102
100
100
115
99
85
78
66
57
Investments
0
1
1
1
1
0
1
1
1
1
690
Other Assets
1,485
1,551
1,597
1,771
1,780
1,733
1,517
1,582
1,449
1,482
0
Total Liabilities
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
2,047
Current Liabilities
1,156
1,240
1,279
1,309
1,300
1,248
1,187
1,004
891
973
1,022
Non Current Liabilities
397
362
296
356
300
249
139
299
234
149
70
Total Equity
958
954
1,007
1,059
1,105
1,136
1,062
1,088
1,065
1,069
956
Reserve & Surplus
936
932
984
1,036
1,083
1,114
1,040
1,066
1,042
1,047
934
Share Capital
22
22
22
22
22
22
22
22
22
22
22

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
23
3
-24
-4
12
0
4
-8
-0
2
Investing Activities
-60
-77
-18
-29
-26
-33
-29
17
52
-17
Operating Activities
144
169
199
65
239
285
21
95
134
225
Financing Activities
-62
-89
-204
-40
-201
-252
12
-119
-186
-205

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
44.53 %
44.53 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
16.97 %
16.61 %
3.24 %
0.73 %
1.65 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.16 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
Public / Retail
22.43 %
21.99 %
22.53 %
23.60 %
23.82 %
24.20 %
24.33 %
24.52 %
24.46 %
24.61 %
24.45 %
24.34 %
23.32 %
23.69 %
30.45 %
39.36 %
41.60 %
Others
21.77 %
22.21 %
21.67 %
20.60 %
20.38 %
20.00 %
5.26 %
5.07 %
5.13 %
4.98 %
5.14 %
5.25 %
3.88 %
3.87 %
10.49 %
15.35 %
12.04 %
No of Share Holders
0
47,394
53,304
55,124
56,073
64,012
63,909
62,940
64,422
61,582
60,283
60,761
59,946
58,230
66,741
69,482
69,241

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Aug 2025 22.76 19.93
07 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Jul 2025 25.05 22.76
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 39.31 32.23
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 38.98 34.57
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 29.93 42.23

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Nectar Lifesciences Limited Has Informed The Exchange Regarding Notice Of Extraordinary General Meeting To Be Held On August 04 20252 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
General Updates5 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
1. Slump Sale Of Business; And 2. Sale Of Assets5 days ago
Financial Results For The Year 2024-255 days ago
Board Meeting Intimation for Annual Audited Financial Results And Other Business Matters.10 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 30, 2025
Closure of Trading WindowJun 27, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 26, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 11, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 30, 2025
Results-Delay in Financial ResultsMay 30, 2025
Board Meeting Outcome for Change In DirectorateMay 30, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 28, 2025
Board Meeting Intimation for Annual Audited Financial Results And Other Business Matters.May 27, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 06, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 03, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 30, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 30, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 01, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 15, 2025
Update On EU Regulatory Inspection And Business StatusMar 13, 2025
Update On EU Regulatory InspectionMar 10, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerFeb 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2025
Integrated Filing (Financial)Jan 31, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 31, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 31, 2025
Unaudited Financial Results For Period Ended On December 31 2024.Jan 31, 2025
Board Meeting Intimation for Financial Results For The Quarter And Nine Months Ended On December 31 2024 And Other Business Matters.Jan 24, 2025
Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 22, 2025
Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 20, 2025
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 10, 2025
Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Disclosure Under Regulation 30 And 30A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015.Dec 13, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 13, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 13, 2024
Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015.Nov 28, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 25, 2024

Technical Indicators